Compare Cardinal Health Inc (CAH) vs Mercadolibre Inc (MELI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Mercadolibre Inc — how do they compare? Cardinal Health Inc trades at $228.8 (market cap $53.89B), while Mercadolibre Inc trades at $1,877.96 (market cap $95.00B). The key difference: Mercadolibre Inc is the larger of the two by market cap, and Cardinal Health Inc pays a 0.89% dividend while Mercadolibre Inc pays none. Which is the better fit depends on your goals.
| CAH | MELI | |
|---|---|---|
Market Cap | $53.89B | $95.00B |
Sector | Health | Consumer Cyclical |
52-Week High | $239.71 | $2.51K |
52-Week Low | $146.04 | $1.55K |
Enterprise Value | $58.87B | $101.89B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
MercadoLibre (MELI) trades at $1,867.30, up 0.81% today, with a bullish technical signal and strong analyst support. Recent financials show robust revenue growth to $28.89 billion in 2025, though net income margins compressed to 6.04%. The stock faces near-term pressure from three consecutive quarterly EPS misses but benefits from expanding cash flow and a dominant position in Latin American e-commerce and fintech.
Outlook remains positive with a consensus price target of $2,230, implying 19% upside, but risks include margin volatility from heavy investments and competitive threats. Institutional sentiment is strong with 72% buy ratings, though high P/E of 49.28 demands sustained growth to justify valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Mercadolibre Inc
MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →
